Search For "renu swarup"
More scientific data required on mixing of COVID-19 vaccine doses: Secreta
Updated : 9 months, 3 weeks ago IST
New Delhi [India], September 16 (ANI): Secretary, Department of Biotechnology, Government of India Dr Renu Swarup said that Drugs Controller General of India has given permission to Christian Medical College, Vellore to start a trial on the mixing of COVID-19 vaccines while adding that th
Read More
Covid pandemic brought strength of our science and technology to forefront
Updated : 9 months, 3 weeks ago IST
New Delhi [India], September 14 (ANI): The COVID-19 pandemic has posed many challenges, but the country has responded extremely well to all of them, said Dr Renu Swarup, Secretary of the Department of Biotechnology on Tuesday.
Read More
India working on developing Pan-Corona shot: Dr Renu Swarup
Updated : 10 months, 2 weeks ago IST
New Delhi [India], August 23 (ANI): Dr Renu Swarup, Director of the Department of Biotechnology on Monday said that the Government Of India (GOI) is working on vaccines with the needed modification to fight against any strain of COVID-19 i.e Pan-Corona Vaccine.
Read More
Third Covid-19 wave will come if we invite it: Dr Renu Swarup
Updated : 10 months, 2 weeks ago IST
New Delhi [India], August 23 (ANI): The third Covid-19 wave will come if "invited" by the human behaviour and that of the virus, said Dr Renu Swarup, Secretary of Department of Biotechnology, Government of India, on Monday.
Read More
India approves Zydus Cadila's ZyCoV-D vaccine for emergency use for adults
Updated : 10 months, 2 weeks ago IST
New Delhi [India], August 20 (ANI): Zydus Cadila's wait for a regulatory nod for its ZyCoV-D plasmid DNA vaccine against Covid is over. The Ahmedabad-based pharma company has received approval from the Drugs Controller General of India (DCGI).
Read More
ADB establishes high-level advisory group for Covid-19 vaccines
Updated : 12 months ago IST
Manila [The Philippines], July 5 (ANI): The Asian Development Bank (ADB) has joined with leading public health experts, vaccine regulators and policymakers to form an advisory group to provide its developing member countries (DMCs) with expert technical and scientific advice on the quality,
Read More
Production of COVID vaccines is being augmented, won't be difficult to mee
Updated : 1 year, 2 months ago IST
New Delhi [India], April 23 (ANI): The production of COVID-19 vaccines approved by the government is getting augmented and there is a promising pipeline of vaccine candidates and it will not be difficult to fulfill the obligation of vaccinating those over 18 years of age, a senior governm
Read More
Johnson & Johnson's Covid vaccine expected to be imported by June-July
Updated : 1 year, 2 months ago IST
New Delhi [India], April 22 (ANI): Johnson & Johnson's single-shot coronavirus vaccine is expected to be imported to India for "fill and finish" by June or July this year, said Renu Swarup, Secretary, Department of Biotechnology, Ministry of Science and Technology on Thursday.
Read More
Delhi HC gives nod for NCRD, orders to finalise National Health Policy for
Updated : 1 year, 3 months ago IST
New Delhi [India], March 23 (ANI): The Delhi High Court on Tuesday passed several directions for treatment of people suffering from rare diseases including setting up a National Consortium for Rare Disease (NCRD). The Court also directed the Central government to finalise and notify the Nati
Read More
Zydus Cadila gets DCGI nod for Phase-3 clinical trials for Covid-19 vaccin
Updated : 1 year, 6 months ago IST
New Delhi [India], January 4 (ANI): The drug regulatory body Drugs Controller General of India (DCGI) has approved Ahmedabad based drug firm Zydus Cadila to initiate Phase III clinical trials of its Covid-19 vaccine ZyCoV-D.
Read More
DBT's expert committee tracking developments related to COVID-19 vaccine:
Updated : 1 year, 7 months ago IST
New Delhi (India), December 4 (ANI): Department of Biotechnology Secretary Renu Swarup on Friday said that the ministry has set up a vaccine expert committee which will give scientific inputs on regulatory requirements related to COVID-19 vaccine.
Read More
